1. Objective To determine the best plan with penicillamine in treating the patients with hepatolenticular degeneration.

2. Combination of D penicillamine and Methotrexate did not increase the incidence of adverse events.

3. In recent years clinical common penicillamine, glucocorticoid and other drugs to treat the disease, not only long course of treatment, the treatment ineffective, and have more adverse reactions.

4. Objective:To study the effect of penicillamine on preventing intraperitoneal adhesion formation.

5. Conclusion Indirect moxibustion and penicillamine are similar in curative effect. Indirect moxibustion can be regarded as an effective therapy for rheumatoid arthritis.

6. Conclusions: Penicillamine has great effect to inhibit intra-abdominal adhesion formation and reduce the wound breaking strength, but it has no influence on wound healing.

7. OBJECTIVE : To study the hydrolytic technology of the acetylized product of D - penicillamine to obtain L - penicillamine.

8. PURPOSE To compare the efficacy and urinary copper excretion in the treatment of hepatolenticular degeneration (HLD) with penicillamine and zinc.

9. Objective To improve clinicians'understanding of nephrotic syndrome and myasthenia gravis as adverse events of penicillamine(D-PA).

10. Objective: To develop a method for the impurity determination of sulbactam penicillamine in sulbactam sodium.

11. Structure and purity of the product were confirmed by 1 H NMR and specific rotatory power. The yield of D Penicillamine was 64%.

12. After discharge, the maintaining therapy given to them was dimercaptosuccinic acid and penicillamine alternatively combined with Gandou tablet and zinc gluconate orally.

13. OBJECTIVE : To study the process of acetylized racemization of D - penicillamine in the acidic condition.

14. Objective To analyse the concentrations of 21 elements in 24 h urine of patients with Wilson's disease (WD) during penicillamine therapy.

15. Objective To explore the effect of Antisclerosis Composite Prescription ACP and penicillamine on scleroderma mouse.

16. A method is presented for the chiral separation of penicillamine enantiomers.